BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17150261)

  • 41. Inhibition of protein prenylation by patulin.
    Miura S; Hasumi K; Endo A
    FEBS Lett; 1993 Feb; 318(1):88-90. PubMed ID: 8436232
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Druggability of the enzymes of the non-mevalonate-pathway.
    Masini T; Kroezen BS; Hirsch AK
    Drug Discov Today; 2013 Dec; 18(23-24):1256-62. PubMed ID: 23856326
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biochemical modulation of anticancer drugs.
    Kanamaru R; Ishioka C; Konishi Y; Ishikawa A; Shibata H; Wakui A
    Sci Rep Res Inst Tohoku Univ Med; 1988 Dec; 35(1-4):18-28. PubMed ID: 3076265
    [No Abstract]   [Full Text] [Related]  

  • 44. Regulation of mevalonate metabolism in cancer and immune cells.
    Thurnher M; Gruenbacher G; Nussbaumer O
    Biochim Biophys Acta; 2013 Jun; 1831(6):1009-15. PubMed ID: 23524243
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The potential successes and challenges of targeted anticancer therapies.
    Keefe D; Stringer A
    Curr Opin Support Palliat Care; 2010 Mar; 4(1):16-8. PubMed ID: 20009759
    [No Abstract]   [Full Text] [Related]  

  • 46. Bifunctional inhibitors of mevalonate kinase and mevalonate 5-diphosphate decarboxylase.
    Qiu Y; Li D
    Org Lett; 2006 Mar; 8(6):1013-6. PubMed ID: 16524256
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel benzimidazole phosphonates as potential inhibitors of protein prenylation.
    Bhuiyan NH; Varney ML; Wiemer DF; Holstein SA
    Bioorg Med Chem Lett; 2019 Dec; 29(24):126757. PubMed ID: 31699606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel prenyltransferase enzymes as a tool for flavonoid prenylation.
    Botta B; Delle Monache G; Menendez P; Boffi A
    Trends Pharmacol Sci; 2005 Dec; 26(12):606-8. PubMed ID: 16229901
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prenylation Defects and Oxidative Stress Trigger the Main Consequences of Neuroinflammation Linked to Mevalonate Pathway Deregulation.
    Pisanti S; Rimondi E; Pozza E; Melloni E; Zauli E; Bifulco M; Martinelli R; Marcuzzi A
    Int J Environ Res Public Health; 2022 Jul; 19(15):. PubMed ID: 35897423
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Mechanism of the induction of apoptosis in cancer cells].
    Nakaya K
    Seikagaku; 1996 Dec; 68(12):1808-12. PubMed ID: 9014490
    [No Abstract]   [Full Text] [Related]  

  • 51. Protein farnesylation and disease.
    Novelli G; D'Apice MR
    J Inherit Metab Dis; 2012 Sep; 35(5):917-26. PubMed ID: 22307208
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bioluminescence imaging of prenylation inhibition--letter.
    Clezardin P
    Clin Cancer Res; 2012 Nov; 18(21):6077; author reply 6078. PubMed ID: 23045244
    [No Abstract]   [Full Text] [Related]  

  • 53. Targeting prenylation inhibition through the mevalonate pathway.
    Manaswiyoungkul P; de Araujo ED; Gunning PT
    RSC Med Chem; 2020 Jan; 11(1):51-71. PubMed ID: 33479604
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isoprenoids and neoplastic growth.
    Cave WT
    World Rev Nutr Diet; 1994; 76():70-3. PubMed ID: 7856239
    [No Abstract]   [Full Text] [Related]  

  • 55. Transition state analysis of model and enzymatic prenylation reactions.
    Lenevich S; Xu J; Hosokawa A; Cramer CJ; Distefano MD
    J Am Chem Soc; 2007 May; 129(18):5796-7. PubMed ID: 17439118
    [No Abstract]   [Full Text] [Related]  

  • 56. Probes for protein prenylation.
    Doerr A
    Nat Methods; 2019 Jun; 16(6):459. PubMed ID: 31147650
    [No Abstract]   [Full Text] [Related]  

  • 57. ABL allosteric inhibitors synergize with statins to enhance apoptosis of metastatic lung cancer cells.
    Luttman JH; Hoj JP; Lin KH; Lin J; Gu JJ; Rouse C; Nichols AG; MacIver NJ; Wood KC; Pendergast AM
    Cell Rep; 2021 Oct; 37(4):109880. PubMed ID: 34706244
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulation of Small GTPase Prenylation in the Nervous System.
    Reddy JM; Raut NGR; Seifert JL; Hynds DL
    Mol Neurobiol; 2020 May; 57(5):2220-2231. PubMed ID: 31989383
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Caveolae as a target to quench autoinduction of the metastatic phenotype in lung cancer.
    Garnett DJ
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):611-8. PubMed ID: 26573510
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Statins inhibit proliferation and cytotoxicity of a human leukemic natural killer cell line.
    Crosbie J; Magnussen M; Dornbier R; Iannone A; Steele TA
    Biomark Res; 2013 Dec; 1(1):33. PubMed ID: 24359683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.